首页 | 本学科首页   官方微博 | 高级检索  
     

大肠杆菌Ee株SLT-ⅡeB基因的3拷贝融合表达及其生物学活性与免疫原性
引用本文:刘国平,吴斌,林艺远,金梅林,陈焕春. 大肠杆菌Ee株SLT-ⅡeB基因的3拷贝融合表达及其生物学活性与免疫原性[J]. 微生物学报, 2007, 47(4): 686-691
作者姓名:刘国平  吴斌  林艺远  金梅林  陈焕春
作者单位:1. 华中农业大学农业微生物学国家重点实验室,武汉,430070;长江大学动物科学学院,荆州,434025
2. 华中农业大学农业微生物学国家重点实验室,武汉,430070
基金项目:国家高技术研究发展计划(863计划);湖北省科技攻关项目
摘    要:根据大肠杆菌Ee株主要免疫原性片段SLT-ⅡeB的基因序列,设计合成两对引物,利用谷胱甘肽-S-转移酶(GST)表达系统将三拷贝SLT-ⅡeB的融合基因串联于GST下游,并在大肠杆菌中成功表达,获得了大小约为45kDa融合蛋白GST-3B,表达产物以包涵体形式产生,Western blot检测证实表达的融合蛋白具有良好的生物学活性;结合抑制试验表明,与单拷贝融合表达蛋白GST-B相比,GST-3B与水肿毒素受体的亲和力更强。GST-3B及GST-B与等量弗氏不完全佐剂乳化后制成亚单位疫苗,间隔两周两次皮下免疫小鼠。结果GST-3B疫苗组产生的抗体水平明显高于GST-B疫苗组,但两种疫苗组的抗体消长趋势相同。二免后两周用5×LD50的Ee株大肠杆菌进行腹腔攻毒。GST-3B疫苗组保护率为60.0%(6/10),明显优于GST-B疫苗组40.0%(4/10)。研究结果表明GST-3B具有良好的生物学活性和免疫原性,可以作为疫苗添加成分,显示了良好的应用前景。

关 键 词:大肠杆菌  SLT-ⅡeB基因  融合表达  生物学活性  免疫原性
文章编号:0001-6209(2007)04-0686-06
收稿时间:2006-11-21
修稿时间:2007-06-07

Expression of GST-3B fusion protein of Escherichia coli of Ee strain producing SLT-He toxin and study on its biological activities and immunogenicity
LIU Guo-ping,WU Bin,LIN Yi-yuan,JIN Mei-lin and CHEN Huan-chun. Expression of GST-3B fusion protein of Escherichia coli of Ee strain producing SLT-He toxin and study on its biological activities and immunogenicity[J]. Acta microbiologica Sinica, 2007, 47(4): 686-691
Authors:LIU Guo-ping  WU Bin  LIN Yi-yuan  JIN Mei-lin  CHEN Huan-chun
Affiliation:1.State Key Laboratory of Agricultural Microbiology; Huazhong Agriculture University; Wuhan 430070; China;2.College of Animal Science; Yangtze University; Jingzhou 434025; China;State Key Laboratory of Agricultural Microbiology; Huazhong Agriculture University; Wuhan 430070; China;State Key Laboratory of Agricultural Microbiology; Huazhong Agriculture University; Wuhan 430070; China;State Key Laboratory of Agricultural Microbiology; Huazhong Agriculture University; Wuhan 430070; China;State Key Laboratory of Agricultural Microbiology; Huazhong Agriculture University; Wuhan 430070; China
Abstract:Three copies of DNA fragment encoding the truncated SLT-IIeB of Ee strain which was responsible for the edema disease in piglets in Hubei province were fused to the downstream of glutathione S-transferase (GST) of pGEX-KG expression vector, resulting in the fusion expression plasmid pK3B. After transformed into E. coli BL21(DE3) and induced by IPTG, the results of SDS-PAGE showed that the GST-3B fusion protein was expressed in high level. Western blot was performed to confirm that the expressed fusion protein could specifically react with antiserum against diseases of edema of swine. The fusion protein was further purified and used as an antigen for receptor-binding inhibition assay. The receptor-binding inhibition assay showed GST-3B fusion protein had more strong biological activities than GST-B. The fusion protein of GST-3B or GST-B was purified and emulsified with Freund's incomplete adjuvant in equal volumes to get subunit bacterin. Groups of SPF KM mice were vaccinated subcutaneously at 0 week with 25 micrograms and at 2 weeks with 25 micrograms of purified GST-3B or GST-B and challenged intraperitoneally with volume of 5×OD50 Ee strain. Serological tests were performed one week interval with ELISA. The IgG titres against SLT-IIeB in the sera collected at the same period from the Group GST-3B were higher than in the Group GST-B and the immune protection rate against Ee strain was respectively 60% and 40%. These results show the fusion protein GST-3B had more strong biological activities, immunogenicity and better protection against Ee strain, which built a good foundation for the further research of high efficacy vaccine against porcine edema disease.
Keywords:SLTEC    SLT-IIeB    fusion expression    biological activities    immunogenicity
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《微生物学报》浏览原始摘要信息
点击此处可从《微生物学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号